Kite Pharma
Gilead’s Breakthrough CAR-T Becomes First to Get FDA Approval for Indolent Follicular Lymphoma
2021-03-07
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
LATEST
Amaran Biotech Crowned “Best CDMO in Automated Aseptic Filling” at Taiwan Biopharma Excellence Awards 2025!
2025-03-26
Psychedelics Inching Forward – Psilocybin Therapy Shows Sustained Benefits for Treatment-Resistant Depression
2025-03-24